A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

NCT00902291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Pancreatic Ductal
Pancreatic Cancer
Pancreatic Disease

Interventions

BIOLOGICAL: AGS-1C4D4
BIOLOGICAL: Gemcitabine

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]